Diflunisal (Purpose Pharma)

二氟尼柳(Purpose Pharma)

Report date: 2026/03/24 20:00:35

Base Information

Drug NameDiflunisal (Purpose Pharma)
Drug Alias Namediflunisalum (Purpose Pharma)Attrogy
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsTransthyretin amyloidosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsTransthyretin amyloidosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A